Orlando, FL-A study from Washington University, St. Louis, may have torpedoed a long-standing misconception concerning the pain-relieving benefits of kidney cyst decortication, while at the same time, raising a question whose answer could have important clinical implications.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.